High Ultra-Processed Food Consumption Is Associated with Clinical Exacerbation in Patients with Crohn's Disease in Remission: A Prospective Cohort Study
- PMID: 40393424
- PMCID: PMC12185055
- DOI: 10.1159/000546486
High Ultra-Processed Food Consumption Is Associated with Clinical Exacerbation in Patients with Crohn's Disease in Remission: A Prospective Cohort Study
Abstract
Introduction: Diet can impact the clinical course of Crohn's disease (CD). However, the importance of food processing level is uncertain. We aimed to evaluate whether ultra-processed foods (UPFs) are associated with an increased risk of relapse among patients with CD in clinical remission.
Methods: In this prospective cohort study, adult patients with CD in clinical remission were followed for 1 year or until clinical relapse, as assessed by the Harvey Bradshaw index. Dietary intake was assessed using a food frequency questionnaire and a dedicated validated processed food questionnaire to evaluate UPF consumption. Multivariable Cox proportional hazard models were used to estimate the adjusted hazard ratio of disease relapse according to high or low UPF consumption.
Results: A total of 111 patients with CD (mean age 37.9 ± 14.0 years) in clinical remission were followed. Over a median period of 12 months [interquartile range, 8-12], 24 patients (21.6%) experienced clinical relapse. Fecal calprotectin levels were increased at the relapse visit compared to baseline (193.0 μg/g [114.0-807.0] and 79.0 μg/g [17.0-274.5], respectively, p = 0.002). A higher intake of UPFs was associated with an increased risk of CD relapse (HR = 3.86; 95% CI 1.30-11.47). Ultra-processed breads and pastries, as well as oils and spreads, were the UPF subgroups with the strongest positive associations (HR = 3.27; 95% CI 1.26-8.45 and HR = 2.76; 95% CI 1.02-7.45, respectively).
Conclusion: UPF consumption is associated with an increased risk of relapse in patients with CD in remission. This study, along with future research, can contribute to establishing nutritional guidelines aimed at reducing UPF consumption in this population.
Keywords: Diet; Inflammatory bowel diseases; Processed food questionnaire; Ultra-processed foods.
© 2025 The Author(s). Published by S. Karger AG, Basel.
Conflict of interest statement
C.S.-S. received support from Wolfson Medical Center IP for Nestle Health Science and speaking fees from Nestle and Takeda. N.M. received speaking and/or consulting fees from Pfizer, Takeda, Janssen, Ferring, BMS, Nestle, and Eli Lilly and grant support from Takeda, Janssen, Abbott, AbbVie, Pfizer, BMS, and Nestle. T.T. received speaking and/or consulting fees from Takeda and AbbVie. The remaining authors disclose no conflicts.
Figures



References
-
- Baumgart DC, Sandborn WJ. Crohn’s disease. Lancet. 2012;380(9853):1590–605. - PubMed
-
- Huppertz-Hauss G, Lie Høivik M, Jelsness-Jørgensen LP, Henriksen M, Høie O, Jahnsen J, et al. Health-related quality of life in patients with inflammatory bowel disease 20 Years after diagnosis: results from the IBSEN study. Inflamm Bowel Dis. 2016;22(7):1679–87. - PubMed
-
- Peters V, Spooren CEGM, Pierik MJ, Weersma RK, Van Dullemen HM, Festen EAM, et al. Dietary intake pattern is associated with occurrence of flares in IBD patients. J Crohns Colitis. 2021;15(8):1305–15. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical